DK1573022T3 - Nukleinsyre og tilsvarende protein betegnet 184P1E2, der er egnede til behandling og påvisning af cancer - Google Patents

Nukleinsyre og tilsvarende protein betegnet 184P1E2, der er egnede til behandling og påvisning af cancer

Info

Publication number
DK1573022T3
DK1573022T3 DK02731360.0T DK02731360T DK1573022T3 DK 1573022 T3 DK1573022 T3 DK 1573022T3 DK 02731360 T DK02731360 T DK 02731360T DK 1573022 T3 DK1573022 T3 DK 1573022T3
Authority
DK
Denmark
Prior art keywords
cancer
detection
treatment
nucleic acid
corresponding protein
Prior art date
Application number
DK02731360.0T
Other languages
English (en)
Inventor
Arthur B Raitano
Mary Faris
Rene S Hubert
Karen Morrison
Robert Kendall Morrison
Aya Jakobovits
Pia M Chalitta-Eid
Wangmao Ge
Original Assignee
Agensys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agensys Inc filed Critical Agensys Inc
Application granted granted Critical
Publication of DK1573022T3 publication Critical patent/DK1573022T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK02731360.0T 2001-04-10 2002-04-09 Nukleinsyre og tilsvarende protein betegnet 184P1E2, der er egnede til behandling og påvisning af cancer DK1573022T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28273901P 2001-04-10 2001-04-10
US28663001P 2001-04-25 2001-04-25
PCT/US2002/011643 WO2002083919A2 (en) 2001-04-10 2002-04-09 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer

Publications (1)

Publication Number Publication Date
DK1573022T3 true DK1573022T3 (da) 2011-09-12

Family

ID=26961649

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02731360.0T DK1573022T3 (da) 2001-04-10 2002-04-09 Nukleinsyre og tilsvarende protein betegnet 184P1E2, der er egnede til behandling og påvisning af cancer

Country Status (9)

Country Link
US (8) US7135549B1 (da)
EP (1) EP1573022B1 (da)
AT (1) ATE512216T1 (da)
AU (1) AU2002303340A1 (da)
CA (1) CA2443147A1 (da)
CY (1) CY1113064T1 (da)
DK (1) DK1573022T3 (da)
PT (1) PT1573022E (da)
WO (2) WO2002083860A2 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7135549B1 (en) 2001-04-10 2006-11-14 Agensys, Inc. Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer
US7589058B2 (en) 2002-07-23 2009-09-15 Ipsen Pharma, S.A.S. Ghrelin analogs
GB2414480B (en) * 2003-02-07 2007-06-27 Wisconsin Alumni Res Found Directed genetic modifications of human stem cells
KR101312339B1 (ko) * 2005-04-20 2013-09-27 주식회사 바이로메드 융합 단백질 분리를 위한 조성물 및 방법
US20100203553A1 (en) * 2009-02-11 2010-08-12 Abdeen Suad M Histochemical and biomarker for liver fibrosis
US8449512B2 (en) 2010-04-09 2013-05-28 Davinci Biomedical Research Products Inc. Stoma stabilitating device and method
WO2012075411A1 (en) * 2010-12-03 2012-06-07 The Board Of Trustees Of The Leland Stanford Junior University Quantitative aggregation sensors
WO2013101611A1 (en) 2011-12-30 2013-07-04 Abbott Molecular Inc. Materials and methods for diagnosis of bladder cancer and monitoring recurrence thereof
US9889192B2 (en) 2012-10-01 2018-02-13 Thomas Jefferson University Immunization with rabies virus vector expressing foreign protein antigen
KR102369010B1 (ko) * 2013-08-27 2022-03-02 더 로얄 인스티튜션 포 디 어드밴스먼트 오브 러닝/맥길 유니버시티 연골 및 디스크 조직 병리들의 치료를 위한 방법들 및 조성물들

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
US5976535A (en) * 1992-06-09 1999-11-02 Neorx Corporation Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore
US5872094A (en) * 1993-01-06 1999-02-16 The General Hospital Corporation Method for attaching cartilaginous tissue, cartilage matrix protein or link protein to a surface
WO1996009395A2 (de) 1994-09-21 1996-03-28 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Arzneimittel zur prophylaxe und behandlung von und diagnostika zur erkennung von autoimmunkrankheiten und viralen erkrankungen
CA2265889A1 (en) * 1996-09-06 1998-03-12 The Regents Of The University Of California E25a protein, methods for production and use thereof
CA2328108A1 (en) 1998-05-07 1999-11-11 The Regents Of The University Of California Use of neglected target tissue antigens in modulation of immune responses
AU3395900A (en) 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
CA2383592A1 (en) 1999-03-31 2000-10-05 Curagen Corporation 2384891 acids including open reading frames encoding polypeptides; orfx
IL132611A0 (en) 1999-10-27 2001-03-19 Yeda Res & Dev Synthetic genes and polypeptides and pharmaceutical compositions comprising them
US20020119452A1 (en) 2000-01-18 2002-08-29 Phippard Deborah J. Osteoarthritis tissue derived nucleic acids, polypeptides, vectors, and cells
JP2003521902A (ja) 2000-01-20 2003-07-22 ユニバーシティ オブ バージニア パテント ファウンデーション 卵特異的表面タンパク質
AU2001241418A1 (en) 2000-01-31 2001-08-07 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
EP1290217A2 (en) 2000-02-04 2003-03-12 Aeomica, Inc. Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence
US6436703B1 (en) 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
AU2001256780A1 (en) 2000-05-18 2001-11-26 Nihon University, School Juridical Person Method for examining ischemic conditions
WO2002010449A2 (en) 2000-07-28 2002-02-07 Compugen Inc. Oligonucleotide library for detecting rna transcripts and splice variants that populate a transcriptome
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
WO2003010327A2 (en) 2001-02-21 2003-02-06 Curagen Corporation Novel proteins and nucleic acids encoding same
US7135549B1 (en) * 2001-04-10 2006-11-14 Agensys, Inc. Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer
IL158223A0 (en) 2001-05-03 2004-05-12 Akzo Nobel Nv Peptidylarginine deiminase 6

Also Published As

Publication number Publication date
AU2002303340A1 (en) 2002-10-28
US20040062761A1 (en) 2004-04-01
EP1573022A4 (en) 2008-01-09
US20070054284A1 (en) 2007-03-08
WO2002083860A2 (en) 2002-10-24
US20090264381A1 (en) 2009-10-22
AU2002303340A8 (en) 2007-08-30
US7135549B1 (en) 2006-11-14
US7879570B2 (en) 2011-02-01
US8168187B2 (en) 2012-05-01
EP1573022A2 (en) 2005-09-14
US7592149B2 (en) 2009-09-22
WO2002083919A2 (en) 2002-10-24
US20110110952A1 (en) 2011-05-12
US7960527B2 (en) 2011-06-14
EP1573022B1 (en) 2011-06-08
WO2002083860A9 (en) 2013-11-07
US20100168214A1 (en) 2010-07-01
CA2443147A1 (en) 2002-10-24
CY1113064T1 (el) 2016-04-13
US7667015B2 (en) 2010-02-23
US20090148854A1 (en) 2009-06-11
WO2002083919A3 (en) 2007-06-28
US20110123539A1 (en) 2011-05-26
ATE512216T1 (de) 2011-06-15
PT1573022E (pt) 2011-08-23

Similar Documents

Publication Publication Date Title
WO2003022995A3 (en) Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
WO2003040340A3 (en) Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
WO2004016799A3 (en) NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 191P4D12(b) USEFUL IN TREATMENT AND DETECTION OF CANCER
DK1629088T3 (da) Varianter af prostatastamcelleantigen (psca) og undersekvenser deraf
CY1113064T1 (el) Νουκλεϊνικο οξυ και αντιστοιχη πρωτεϊνη με τιτλο 184ρ1ε2 χρησιμα στη θεραπεια και ανιχνευση καρκινου
IL181218A0 (en) Nucleic acids and corresponding 58p1d12 proteins for use in the detection and treatment of cancer
WO2003050255A3 (en) Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
WO2004098515A3 (en) Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer
WO2002072785A3 (en) Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer
WO2004067716A3 (en) Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer
WO2002060953A3 (en) Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer
WO2002083928A3 (en) Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
WO2006055004A8 (en) Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer
WO2002092842A3 (en) Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
WO2004050828A3 (en) Nucleic acid corresponding protein entitled 24p4c12 useful in treatment and detection of cancer
WO2002095009A3 (en) Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer
MXPA05002520A (es) Secuencia de acido nucleico 98p4b6 asociada con el cancer.
DK1553980T3 (da) Nukleinsyre og tilsvarende protein med betegnelsen 238P1B2, egnet til behandling og påvisning af cancer
DK1434592T3 (da) Nukleinsyre og tilsvarende protein med betegnelsen 121P2A3, som er anvendelige til behandling og detektion af cancer